Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)

Clinical trial NCT07215650 · RECRUITING

Trial details

NCT number: NCT07215650
Sponsor: Candid Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Generalized Myasthenia Gravis

Start date: 2025-09-16
Primary completion: 2027-12-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.